Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta‐analysis

UNLABELLED: Chronic hepatitis B viral (HBV) infection remains a significant global health problem. Evidence-based guidelines are needed to help providers determine when treatment should be initiated, which medication is most appropriate, and when treatment can safely be stopped. The American Association for the Study of Liver Diseases HBV guideline methodology and writing committees developed a protocol a priori for this systematic review. We searched multiple databases for randomized controlled trials and controlled observational studies that enrolled adults ≥18 years old diagnosed with chronic HBV infection who received antiviral therapy. Data extraction was done by pairs of independent reviewers. We…

• BS
  Bristol-Myers Squibb
• AA
  American Association for the Study of Liver Diseases
• GS
  Gilead Sciences